Caas Capital Management LP Spring Works Therapeutics, Inc. Put Options Transaction History
Caas Capital Management LP
- $552 Million
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SWTX
# of Institutions
242Shares Held
70.7MCall Options Held
144KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA7.16MShares$424 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$333 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.84MShares$228 Million4.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.52MShares$208 Million0.01% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$203 Million5.82% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $3.7B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...